Inaktiver Wert

Andere Sprachen CorMedix Inc. Nyse

Aktien

US21900C1009

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

CorMedix Begins Outpatient Distribution of DefenCath	03.07.
CorMedix Inc. Announces Outpatient Availability of DefenCath	03.07.
CorMedix Inc. Receives FDA Feedback on Potential Label Expansion	18.06.
CorMedix Inc. Announces CMS Grants Pass-Through Status to Defencath	06.06.
CorMedix Shares Rise on Multiyear DefenCath Supply Deal	28.05.
CorMedix Inc. Announces Commercial Agreement With Top Tier Dialysis Provider	28.05.
CorMedix Inc. Announces Commercial Agreement with Top Tier Dialysis Provider	28.05.
CORMEDIX INC. TO PARTICIPATE IN TWO UPCOMING INVESTOR CONFERENCES	13.05.
CorMedix Inc. to Participate in Two Upcoming Investor Conferences	10.05.
CorMedix Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09.05.
CorMedix: Q1 Earnings Snapshot	09.05.
CorMedix Inc. Reports First Quarter 2024 Financial Results and Provides Business Update	09.05.
Actinium Pharmaceuticals (ATNM) Poised for Breakout as Analysts Project Significant Upside	09.05.
CorMedix Inc. To Report First Quarter 2024 Financial Results and Provide a Corporate Update on May 9, 2024	06.05.
CORMEDIX INC. ANNOUNCES CMS GRANTS TDAPA TO DEFENCATH	22.04.
CorMedix Inc. Announces CMS Grants TDAPA to DefenCath	19.04.
CORMEDIX INC. ANNOUNCES U.S. INPATIENT COMMERCIAL AVAILABILITY OF DEFENCATH	16.04.
CorMedix's DefenCath Now Commercially Available For US Inpatient Use	15.04.
CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath® (Taurolidine and Heparin)	15.04.
CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath®? (Taurolidine and Heparin)	15.04.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen CorMedix Inc. Nyse

Aktien

US21900C1009

Andere Sprachen

Filter